"Het Alexander Monro Ziekenhuis is gespecialiseerd in borstkanker, overige borstaandoeningen, erfelijke aanleg en vervolg na bevolkingsonderzoek. Wij bieden verzekerde zorg voor iedereen na verwijzing door huisarts of specialist. Bij aankomst op het terrein Berg en Bosch kunt u direct door de slagbomen (gaan vanzelf open zodra er voor staat) en zonder kosten voor de deur parkeren op P9."

During the past decade, Alexander Monro Ziekenhuis conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Alexander Monro Ziekenhuis" #1 collaborator was "Borstkanker Onderzoek Groep" with 3 trials as a collaborator, "The Netherlands Cancer Institute" with 2 trials as a collaborator, "Amgen" with 1 trials as a collaborator, "BOOG Study Center" with 1 trials as a collaborator and "Comprehensive Cancer Centre The Netherlands" with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "Alexander Monro Ziekenhuis" are "Breast Cancer" (3 trials), "Fasting Mimicking Diet" (2 trials), "Neoadjuvant Chemotherapy" (2 trials), "Pathological Complete Response" (2 trials) and "Breast Neoplasm Female" (1 trials). Many other conditions were trialed in "Alexander Monro Ziekenhuis" in a lesser frequency.

Most popular intervention types in "Alexander Monro Ziekenhuis" are "Other" (3 trials), "Drug" (2 trials), "Device" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "CDK 4/6 inhibitor" (1 trials), "Fasting Mimicking diet program" (1 trials), "Fasting mimicking diet" (1 trials), "Fulvestrant" (1 trials) and "Non-Steroidal Aromatase Inhibitor" (1 trials). Other intervention names were less common.

The vast majority of trials in "Alexander Monro Ziekenhuis" are 4 trials for "Female" genders and 2 trials for "All" genders.

Currently, there are NaN active trials in "Alexander Monro Ziekenhuis". undefined are not yet recruiting, 3 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Alexander Monro Ziekenhuis, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Alexander Monro Ziekenhuis, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".